Evidence map›Paper›PMID 36883850›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

Validation of Ligand Tetramers for the Detection of Antigen-Specific Lymphocytes.

Kristin S Fitzpatrick, Hanna N Degefu, Katrina Poljakov, Madeleine G Bibby, Allison J Remington, Tyler G Searles, Matthew D Gray, Jim Boonyaratanakornkit, Pamela C Rosato, Justin J Taylor

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Isolation of Rare Antigen-Specific Memory B Cells via Antigen Tetramers.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kristin S FitzpatrickImmunology and Vaccine Development Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0001-8086-5239
Hanna N DegefuDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth College, Lebanon, NH.
Katrina PoljakovImmunology and Vaccine Development Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
Madeleine G BibbyImmunology and Vaccine Development Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
Allison J RemingtonImmunology and Vaccine Development Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0001-5155-4116
Tyler G SearlesDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth College, Lebanon, NH.ORCID 0000-0003-3146-4812
Matthew D GrayImmunology and Vaccine Development Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-4260-9784
Jim BoonyaratanakornkitImmunology and Vaccine Development Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0001-5858-2662
Pamela C RosatoDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth College, Lebanon, NH.ORCID 0000-0001-7909-3868
Justin J TaylorImmunology and Vaccine Development Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0001-9718-2901

Funding

Understanding the role of RNA-binding protein mutations in cancerP20GM113132 · NIGMS · DARTMOUTH COLLEGE · PI MADDEN, DEAN R · 2016 to 2025
$25.9M
Identification and Analysis of HIV-specific Naive B cells in HIV-unexposed IndividualsR01AI122912 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TAYLOR, JUSTIN J · 2016 to 2020
$2.7M
Molecular Medicine Training ProgramT32GM095421 · NIGMS · UNIVERSITY OF WASHINGTON · PI HAWN, THOMAS R, LILES, W. CONRAD · 2011 to 2020
$1.6M
NIAID NIH HHS R01 AI122912NIGMS NIH HHS P20 GM113132NIGMS NIH HHS T32 GM095421
6 · The paper itself

Abstract

The study of Ag-specific lymphocytes has been a key advancement in immunology over the past few decades. The development of multimerized probes containing Ags, peptide:MHC complexes, or other ligands was one innovation allowing the direct study of Ag-specific lymphocytes by flow cytometry. Although these types of study are now common and performed by thousands of laboratories, quality control and assessment of probe quality are often minimal. In fact, many of these types of probe are made in-house, and protocols vary between laboratories. Although peptide:MHC multimers can often be obtained from commercial sources or core facilities, few such services exist for Ag multimers. To ensure high quality and consistency with ligand probes, we have developed an easy and robust multiplexed approach using commercially available beads able to bind Abs specific for the ligand of interest. Using this assay, we have sensitively assessed the performance of peptide:MHC and Ag tetramers and have found considerable batch-to-batch variability in performance and stability over time more easily than using murine or human cell-based assays. This bead-based assay can also reveal common production errors such as miscalculation of Ag concentration. This work could set the stage for the development of standardized assays for all commonly used ligand probes to limit laboratory-to-laboratory technical variation and experimental failure caused by probe underperformance.

Indexed as

PeptidesT-Lymphocytes, CytotoxicAnimalsHistocompatibility AntigensHistocompatibility Antigens Class IHLA-A2 AntigenHumansLigandsMiceHistocompatibility AntigensHistocompatibility Antigens Class IHLA-A2 AntigenLigandsPeptides

Identifiers

PMID36883850
PMCPMC10073333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.